Deltex Medical Group PLC (LSE:DEMG) - Share price - Overview

Stock Report

Deltex Medical Group PLC DEMG

Last Price
GBX4.00

Day Change
0.00|0.00%

As of 24/04/2017
16:26:30 BST | GBX
Minimum 15 Minutes Delay.

Last Close4.00p
Day Range3.88 - 4.00
Mkt Cap11.87Mil
52-Wk Range3.50 - 5.97
Yield %0.00
ISINGB0059337583
Volume41,900
P/E-2.63
P/S1.35
P/CF-5.14

Share Price

Total Returns 25/04/2017

 Chg (%)  
More ...
Deltex Medical Group PLC3.23 
FTSE 100 TR GBP-0.54
 
Financials
201320142015
More ...
Income Statement
Turnover7.156.516.41
Operating Profit-2.10-2.99-3.49
Net Profit-2.11-2.95-3.46
Reported EPS-1.30-1.50-1.60
Balance Sheet
Current Assets5.587.104.13
Non Current Assets2.102.492.58
Total Assets7.689.596.71
Current Liabilities3.143.554.63
Total Liabilities4.304.724.78
Total Equity3.374.871.92
Cash Flow
Operating Cash Flow-1.43-1.82-1.71
Net Change in Cash0.791.46-2.36
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2016-2.90-0.94--4.27---
2017-2.05-0.59--6.84---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
18/05/2016PurchaseMr. Nigel Keen4.00833,32533,333.00
18/05/2016PurchaseProf Sir Duncan Nichol4.00330,00013,200.00
18/05/2016PurchaseMr. Julian Cazalet4.00330,00013,200.00
18/05/2016PurchaseMr. Mark Wippell4.00357,19714,288.00

Company Profile

Deltex Medical Group PLC is a holding company of a group of subsidiary undertakings engaged in the research, development, manufacture and sale of of Fluid Management devices, which include the CardioQ-ODM and CardioQ-ODM+.

Sector

Medical Devices

Market Position

1495 of 1850 Companies

Index

FTSE AIM All Share

Outlook

(18/01/2017) "Group revenues for 2016 expected to be £6.30m"

Next Event 27/04/2017

Next annual report due
Ratios
CompSecMkt
More ...
PER (E)-6.8418.5716.18
Div Yld (E)0.001.714.20
PEG (E)0.000.720.96
ROCE-171.9615.49-78.17
Op Mrgn-51.91-3.67-16.89
EPS Grwth0.0032.5527.46
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Nigel Keen
Chief Executive OfficerMr. Ewan Phillips
Group Finance DirectorMr. Jonathan Shaw
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.